Mechanical Thrombectomy System
Venous In-Stent Restenosis (ISR) and Native Vessel Thrombotic Occlusions
Pre-clinicalActive
Key Facts
Indication
Venous In-Stent Restenosis (ISR) and Native Vessel Thrombotic Occlusions
Phase
Pre-clinical
Status
Active
Company
About InterVene
InterVene is a clinical-stage medical device company pioneering a novel mechanical thrombectomy system for treating complex venous obstructions, particularly venous in-stent restenosis (ISR) and chronic post-thrombotic occlusions. Its technology targets a large, underserved patient population suffering from post-thrombotic syndrome (PTS), where current interventional strategies like balloon angioplasty and stent relining are often ineffective. Led by a seasoned management team with deep vascular device expertise and backed by venture capital, the company is positioned to reshape the interventional treatment paradigm for these debilitating venous conditions.
View full company profile